Pixantrone Progresses Toward Approval in the European Union Medscape In addition, the CHMP noted that the benefit of pixantrone appeared to be lower in patients who had used rituximab in the past, and that its benefit was not established when used as a fifth round of chemotherapy, or later, in patients whose disease did ... |
